Last updated: May 12, 2021
Sponsor: Hospital de Clinicas de Porto Alegre
Overall Status: Active - Recruiting
Phase
N/A
Condition
Fibromyalgia
Treatment
N/AClinical Study ID
NCT04890964
36995020.3.0000.5327
Ages 30-65 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Women aged 30 to 65 years; who can read and write, with a confirmed diagnosis of FMaccording to the criteria of the American College of Rheumatology (2010-2016). Painscore equal to or greater than six on the Numeric Pain Scale (NPS 0-10) on most daysin the last 3 months.
Exclusion
Exclusion Criteria:
- Living outside Porto Alegre area and pregnancy.
- Contraindications to TMS and tDCS: metallic implant in the brain; medical devicesimplanted in the brain, cardiac pacemaker; aneurysmal clip; metallic cochlearprosthesis, ear implants, and non-removable hearing aids; infusion pumps (includingimplantable); cranial halos. Pregnant women, shift work, use of exogenous melatonin,history of alcohol or drug abuse in the last 6 months, neurological pathologies,history of head trauma or neurosurgery, decompensated systemic chronic diseases,chronic inflammatory diseases (lupus, rheumatoid arthritis, Reiter's syndrome),personal history of cancer, past or under treatment.
Study Design
Total Participants: 66
Study Start date:
February 01, 2021
Estimated Completion Date:
December 10, 2022
Study Description
Connect with a study center
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande Do Sul 90.450-120
BrazilActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.